As a result, a statistically significant increase in the number of peripheral blood CD4+CD282+ cells has been found in patients with COPD GOLD II and III with both Th1 and Th17 cytokine profiles compared to the control group. This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.